Divis Laboratories provides update on USFDA inspection

Explore Business Standard
Associate Sponsors
Co-sponsor

Conducted at Unit-II at Visakhapatnam, Andhra Pradesh
Divis Laboratories announced that the Company's Unit-II at Visakhapatnam, Andhra Pradesh has had an inspection by the US-FDA from 29 November 2016 to 06 December 2016. The Company have been issued a form 483 with 5 observations and these shall be responded within the time permitted.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
First Published: Dec 07 2016 | 5:03 PM IST